German, Pain

German Pain Centers Face Widespread Closure as 20 Million Patients Wait Longer for Care

05.06.2026 - 02:34:14 | boerse-global.de

22% of pain treatment centers in Germany may close, threatening care for 20M chronic pain patients, even as arthroscopic surgeries and new therapies emerge.

German Pain Clinics Face Closure Amid Surgery Advances and Chronic Pain Crisis
German - German Pain Centers Face Widespread Closure as 20 Million Patients Wait Longer for Care 05.06.2026 - Bild: über boerse-global.de

More than one in five specialized pain treatment centers in Germany may soon shut down, according to a warning issued by the German Pain Society (Deutsche Schmerzgesellschaft) in early June. President Frank Petzke said the figure stands at 22 percent of all sites — and those at-risk locations handle nearly half of the country‘s chronic pain cases. Planned health reforms and cost-cutting measures are the driving force behind the existential threat.

The looming closures come at a time when surgical options for joint problems are expanding rapidly. Specialized clinics such as the German Joint Center in Heidelberg increasingly rely on arthroscopic procedures for shoulder instability, impingement syndrome, and rotator cuff tears. Dr. med. Sven Lichtenberg, a shoulder surgery expert, described the operations as minimally invasive, with the goal of restoring joint function and preventing long-term damage. Similarly, Prof. Dr. med. Marc Schnetzke, a specialist in elbow stiffness and chronic instability, also uses the same gentle technique.

Yet the surgical advances stand in stark contrast to the broader care crisis. An estimated 20 million people in Germany live with chronic pain, a number expected to rise as the population ages. Lilit Flöther from Halle University Hospital noted that demand for interdisciplinary treatment is climbing, while waiting lists are already stretched thin. Office workers increasingly complain of neck and shoulder pain — a trend observed even abroad, as Hanoi’s Bach Mai Hospital reports rising cases of cervical spondylosis and disc herniations.

To address the treatment gap, researchers are pursuing new rehabilitation protocols and safer medication alternatives. The CRISP study, led by Dr. Marisa Pontillo, evaluates shoulder recovery through functional tests aiming for full return to capacity. For chronic back pain, the NeuroPain study at LMU Klinikum Munich will begin in June 2026, testing focused ultrasound therapy tailored to individual fMRI data. Experts also warn against long-term ibuprofen use for joint pain due to risks of stomach irritation and kidney damage; they recommend physiotherapy, weight management, and exercise instead. Tools such as the “Pressure Pointer” now allow patients to treat trigger points at home.

On the frontier of spinal repair, researchers at ETH Zurich and the University of Zurich have developed magnetic-field-controlled microrobots made from stem cells. In animal trials, these so-called NPC-Bots successfully repaired spinal cord injuries and significantly improved mobility. The technology remains experimental, but for the millions waiting on care, it offers a glimpse of what might eventually fill a growing gap in Germany’s pain medicine landscape.

en | boerse | 69485134 |